GOSSAMER BIO INC (GOSS) Fundamental Analysis & Valuation

NASDAQ:GOSS • US38341P1021

Current stock price

0.3698 USD
+0 (+0.54%)
At close:
0.369 USD
0 (-0.22%)
After Hours:

This GOSS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. GOSS Profitability Analysis

1.1 Basic Checks

  • In the past year GOSS has reported negative net income.
  • In the past year GOSS has reported a negative cash flow from operations.
  • GOSS had negative earnings in each of the past 5 years.
  • GOSS had a negative operating cash flow in each of the past 5 years.
GOSS Yearly Net Income VS EBIT VS OCF VS FCFGOSS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M -150M -200M

1.2 Ratios

  • GOSS's Return On Assets of -98.91% is on the low side compared to the rest of the industry. GOSS is outperformed by 75.92% of its industry peers.
Industry RankSector Rank
ROA -98.91%
ROE N/A
ROIC N/A
ROA(3y)-58.16%
ROA(5y)-65.35%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GOSS Yearly ROA, ROE, ROICGOSS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0 0 0 0 0 0 0 0 0 0

1.3 Margins

  • GOSS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GOSS Yearly Profit, Operating, Gross MarginsGOSS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. GOSS Health Analysis

2.1 Basic Checks

  • GOSS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, GOSS has more shares outstanding
  • The number of shares outstanding for GOSS has been increased compared to 5 years ago.
  • GOSS has a worse debt/assets ratio than last year.
GOSS Yearly Shares OutstandingGOSS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
GOSS Yearly Total Debt VS Total AssetsGOSS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • GOSS has an Altman-Z score of -13.64. This is a bad value and indicates that GOSS is not financially healthy and even has some risk of bankruptcy.
  • GOSS has a worse Altman-Z score (-13.64) than 79.42% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -13.64
ROIC/WACCN/A
WACC7.61%
GOSS Yearly LT Debt VS Equity VS FCFGOSS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M

2.3 Liquidity

  • GOSS has a Current Ratio of 2.64. This indicates that GOSS is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of GOSS (2.64) is worse than 67.96% of its industry peers.
  • A Quick Ratio of 2.64 indicates that GOSS has no problem at all paying its short term obligations.
  • GOSS has a Quick ratio of 2.64. This is in the lower half of the industry: GOSS underperforms 65.83% of its industry peers.
Industry RankSector Rank
Current Ratio 2.64
Quick Ratio 2.64
GOSS Yearly Current Assets VS Current LiabilitesGOSS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. GOSS Growth Analysis

3.1 Past

  • The earnings per share for GOSS have decreased strongly by -188.46% in the last year.
  • The Revenue for GOSS has decreased by -57.74% in the past year. This is quite bad
EPS 1Y (TTM)-188.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40%
Revenue 1Y (TTM)-57.74%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%47.13%

3.2 Future

  • The Earnings Per Share is expected to grow by 18.29% on average over the next years. This is quite good.
  • Based on estimates for the next years, GOSS will show a very strong growth in Revenue. The Revenue will grow by 53.09% on average per year.
EPS Next Y34.72%
EPS Next 2Y32.05%
EPS Next 3Y26.07%
EPS Next 5Y18.29%
Revenue Next Year-53.25%
Revenue Next 2Y18.76%
Revenue Next 3Y45.65%
Revenue Next 5Y53.09%

3.3 Evolution

GOSS Yearly Revenue VS EstimatesGOSS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M
GOSS Yearly EPS VS EstimatesGOSS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -1 -2 -3 -4

More info and screens

Find the best growth stocksShow best growing peers

1

4. GOSS Valuation Analysis

4.1 Price/Earnings Ratio

  • GOSS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year GOSS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GOSS Price Earnings VS Forward Price EarningsGOSS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GOSS Per share dataGOSS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6

4.3 Compensation for Growth

  • GOSS's earnings are expected to grow with 26.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.05%
EPS Next 3Y26.07%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GOSS Dividend Analysis

5.1 Amount

  • No dividends for GOSS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GOSS Fundamentals: All Metrics, Ratios and Statistics

GOSSAMER BIO INC

NASDAQ:GOSS (5/1/2026, 8:00:01 PM)

After market: 0.369 0 (-0.22%)

0.3698

+0 (+0.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Industry Strength55.9
Industry Growth13.04
Earnings (Last)03-17
Earnings (Next)05-12
Inst Owners71.48%
Inst Owner Change0.11%
Ins Owners1.5%
Ins Owner Change4.45%
Market Cap85.59M
Revenue(TTM)48.47M
Net Income(TTM)-170.37M
Analysts75
Price Target4.44 (1100.65%)
Short Float %18.39%
Short Ratio2.14
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.29%
Min EPS beat(2)-7.37%
Max EPS beat(2)-5.22%
EPS beat(4)2
Avg EPS beat(4)2.93%
Min EPS beat(4)-7.37%
Max EPS beat(4)16.34%
EPS beat(8)5
Avg EPS beat(8)3.51%
EPS beat(12)9
Avg EPS beat(12)5.16%
EPS beat(16)11
Avg EPS beat(16)4.24%
Revenue beat(2)2
Avg Revenue beat(2)92.86%
Min Revenue beat(2)79.84%
Max Revenue beat(2)105.89%
Revenue beat(4)4
Avg Revenue beat(4)120.91%
Min Revenue beat(4)79.84%
Max Revenue beat(4)159.58%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-53.6%
PT rev (3m)-53.86%
EPS NQ rev (1m)1.16%
EPS NQ rev (3m)10.66%
EPS NY rev (1m)10.02%
EPS NY rev (3m)16.7%
Revenue NQ rev (1m)-1.87%
Revenue NQ rev (3m)-19.95%
Revenue NY rev (1m)-36.15%
Revenue NY rev (3m)-55.16%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.77
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.75
EYN/A
EPS(NY)-0.49
Fwd EYN/A
FCF(TTM)-0.74
FCFYN/A
OCF(TTM)-0.74
OCFYN/A
SpS0.21
BVpS-0.53
TBVpS-0.53
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -98.91%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-58.16%
ROA(5y)-65.35%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score0
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 329.17%
Cap/Sales 0.16%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.64
Quick Ratio 2.64
Altman-Z -13.64
F-Score0
WACC7.61%
ROIC/WACCN/A
Cap/Depr(3y)109.72%
Cap/Depr(5y)88.13%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-188.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40%
EPS Next Y34.72%
EPS Next 2Y32.05%
EPS Next 3Y26.07%
EPS Next 5Y18.29%
Revenue 1Y (TTM)-57.74%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%47.13%
Revenue Next Year-53.25%
Revenue Next 2Y18.76%
Revenue Next 3Y45.65%
Revenue Next 5Y53.09%
EBIT growth 1Y-172.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year56.72%
EBIT Next 3Y17.91%
EBIT Next 5Y17.38%
FCF growth 1Y-4840.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4838.47%
OCF growth 3YN/A
OCF growth 5YN/A

GOSSAMER BIO INC / GOSS Fundamental Analysis FAQ

What is the fundamental rating for GOSS stock?

ChartMill assigns a fundamental rating of 1 / 10 to GOSS.


What is the valuation status for GOSS stock?

ChartMill assigns a valuation rating of 1 / 10 to GOSSAMER BIO INC (GOSS). This can be considered as Overvalued.


How profitable is GOSSAMER BIO INC (GOSS) stock?

GOSSAMER BIO INC (GOSS) has a profitability rating of 0 / 10.